Acute myeloblastic leukemia: Daunorubicin is indicated for the treatment of all stages of this disease, either as a single agent or in combination with other antiblastic drugs. It is also the treatment of choice for promyelocytic leukemia. Acute lymphoblastic leukemia: Daunorubicin is very active in inducing remission in this disease.
Daunorubicin: Package Insert / Prescribing Info - Drugs.com
2024年2月19日 · Daunorubicin package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.
VYXEOS is a liposomal combination of daunorubicin, an anthracycline topoisomerase inhibitor, and cytarabine, a nucleoside metabolic inhibitor, that is indicated for the treatment of adults...
Daunorubicin hydrochloride主要透過肝臟代謝，經由膽汁排出體外。建議在 開始進行daunorubicin hydrochloride治療之前，應先監測病人的肝功能，以 免發生併發症。嚴重肝功能不全(Child Pugh C級)的病人不得接受 daunorubicinhydrochloride（請參閱第4節）。 腎功能不全
Daunorubicin Injectable Solution is reserved mainly for the initial therapy of acute leukemia and other forms of malignant tumors which are sensitive to the drug. It is administered by the I.V. route only. Daunorubicin Injectable Solution is injected into the tubing of a running infusion of 100 or 250 mL isotonic solution.
DaunoXome: Package Insert / Prescribing Info - Drugs.com
DaunoXome is a liposomal preparation of daunorubicin formulated to maximize the selectivity of daunorubicin for solid tumors in situ. While in the circulation, the DaunoXome formulation helps to protect the entrapped daunorubicin from chemical and enzymatic degradation, minimizes protein binding, and generally decreases uptake by normal (non ...
2013年6月26日 · Daunorubicin hydrochloride in combination with other approved anticancer drugs is indicated for remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute
Pfizer (Perth) Daunorubicin is a sterile, red, isotonic, preservative free solution. 4. CLINICAL PARTICULARS. Acute lymphocytic (lymphoblastic) leukaemia: Daunorubicin is usually reserved for use in cases shown to be resistant to other drugs.
Daunorubicin is an anthracycline antibiotic which damages DNA by intercalating between base pairs resulting in uncoiling of the helix, ultimately inhibiting DNA synthesis and DNA-dependent RNA synthesis.
Daunorubicin Hydrochloride (Hisun Pharmaceuticals USA, Inc.): …
2023年1月1日 · Daunorubicin hydrochloride injection in combination with other approved anticancer drugs is indicated for remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults.
- 某些结果已被删除
跳至内容